OUR PRODUCTS

MOBILE APPS

GENERAL INFO

INMB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

INmune Bio (INMB) Earnings Date & Reports

INmune Bio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

INMB is expected to report earnings to fall 68.63% to -32 cents per share on October 29

Q3'25

Est.

$-0.33

Q2'25

Missed

by $0.65

Q1'25

Beat

by $0.06

Q4'24

Beat

by $0.15

Q3'24

Missed

by $0.08

The last earnings report on August 07 showed earnings per share of -104 cents, missing the estimate of -40 cents. With 222.57K shares outstanding, the current market capitalization sits at 69.73M.

View a ticker or compare two or three

Compare

INMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For INMB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INMB showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapies that harness the patient's immune system to treat cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

225 NE Mizner Boulevard

Phone

+1 858 964-3720

Employees

Web

https://www.inmunebio.com